Alfuzosin to Relieve Ureteral Stent Discomfort: A Prospective, Randomized, Placebo Controlled Study

Journal of Urology

Volumn 181, Issue 1, 2009, Pages 170-176

  Beddingfield, Richard ^a   Pedro, Renato N ^a   Hinck, Bryan ^a   Kreidberg, Carly ^a   Feia, Kendall ^a   Monga, Manoj ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

alfuzosin; pain; questionnaires; stents; ureter

Indexed keywords

ALFUZOSIN; PLACEBO;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BRONCHITIS; CLINICAL FEATURE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; DYSPEPSIA; FATIGUE; FEMALE; HEADACHE; HUMAN; IMPOTENCE; KIDNEY PAIN; MAJOR CLINICAL STUDY; MALE; NAUSEA; ORTHOSTATIC HYPOTENSION; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PHARYNGITIS; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SINUSITIS; UPPER RESPIRATORY TRACT INFECTION; URETER STENT; URETEROSCOPY; URINARY TRACT DISEASE;

ADRENERGIC ALPHA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUINAZOLINES; STENTS; URETER; YOUNG ADULT;

EID: 57149092292     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.09.026     Document Type: Article

References (20)

1. Zimskind P.D., Fetter T.R., and Wilkerson J.L. Clinical use of long-term indwelling silicone rubber ureteral splints inserted cystoscopically. J Urol 97 (1967) 840
2. Joshi H.B., Stainthorpe A., MacDonagh R.P., Keeley Jr. F.X., Timoney A.G., and Barry M.J. Indwelling ureteral stents: evaluation of symptoms, quality of life and utility. J Urol 169 (2003) 1065
3. Joshi H.B., Okeke A., Newns N., Keeley Jr. F.X., and Timoney A.G. Characterization of urinary symptoms in patients with ureteral stents. Urology 59 (2002) 511
4. Borboroglu P.G., Amling C.L., Schenkman N.S., Monga M., Ward J.F., Piper N.Y., et al. Ureteral stenting after ureteroscopy for distal ureteral calculi: a multi-institutional prospective randomized controlled study assessing pain, outcomes and complications. J Urol 166 (2001) 1651
5. Richter S., Ringel A., Shalev M., and Nissenkorn I. The indwelling ureteric stent: a 'friendly' procedure with unfriendly high morbidity. BJU Int 85 (2000) 408
6. Joshi H.B., Okeke A., Newns N., Kumar P.V.S., Keeley F.X., and Timoney A.G. Prevalence of urinary symptoms in patients with ureteric stents and its assessment using I-PSS and ICS questionnaires. Eur Urol 37 (2000) 125
7. Candela J.V., and Bellman G.C. Ureteral stents: impact of diameter and composition on patient symptoms. J Endourol 11 (1997) 45
8. Thomas R. Indwelling ureteral stents: impact of material and shape on patient comfort. J Endourol 7 (1993) 137
9. Dellabella M., Milanese G., and Muzzonigro G. Efficacy of tamsulosin in the medical management of juxtavesical ureteral stones. J Urol 170 (2003) 2202
10. Porpiglia F., Ghignone G., Fiori C., Fontana D., and Scarpa R.M. Nifedipine versus tamsulosin for the management of lower ureteral stones. J Urol 172 (2004) 568
11. Deliveliotis C., Chrisofos M., Gougousis E., Papatsoris A., Dellis A., and Varkarakis I.M. Is there a role for alpha1-blockers in treating Double-J stent-related symptoms?. Urology 67 (2006) 35
12. Joshi H.B., Newns N., Stainthorpe A., MacDonagh R.P., Keeley Jr. F.X., and Timoney A.G. Ureteral stent symptom questionnaire: development and validation of a multidimensional quality of life measure. J Urol 169 (2003) 1060
13. Joshi H.B., Stainthorpe A., Keeley Jr. F.X., MacDonagh R., and Timoney A.G. Indwelling ureteral stents: Evaluation of quality of life to aid outcome analysis. J Endourol 15 (2001) 151
14. Lee C., Kuskowski M., Premoli J., Skemp N., and Monga M. Randomized evaluation of ureteral stents using validated symptom questionnaire. J Endourol 19 (2005) 990
15. Mosli H.A., Farsi H.M., al-Zimaity M.F., Saleh T.R., and al-Zamzami M.M. Vesicoureteral reflux in patients with double pigtail stents. J Urol 146 (1991) 966
16. Debruyne F., and Narayan P. Tamsulosin improves sexual function with minimal abnormal ejaculation in patients treated for lower urinary tract symptoms suggestive of benign prostatic hyperplasia. BJU Int 90 (2002) 12
17. Lukacs B., Leplege A., Thibault P., and Jardin A. Prospective study of men with clinical benign prostatic hyperplasia treated with alfuzosin by general practitioners: 1-year results. Urology 48 (1996) 731
18. Elhilali M., Emberton M., Matzkin H., van Moorselaar R.J., Hartung R., Harving N., et al. Long-term efficacy and safety of alfuzosin 10 mg once daily: a 2-year experience in 'real-life' practice. BJU Int 97 (2006) 513
19. Carbone Jr. D.J., and Hodges S. Medical therapy for benign prostatic hyperplasia: sexual dysfunction and impact on quality of life. Int J Impot Res 15 (2003) 299
20. Damiano R., Autorino R., de Sio M., Giacobbe A., Palumbo I.M., and D'Armiento M. Effect of tamsulosin in preventing ureteral stent-related morbidity: a prospective study. J Endourol 22 (2008) 651